Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection
NCT07714577
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
HPV16/18 Positive
Interventions
DRUG:
BBM-C101
Sponsor
Tianjin First Central Hospital